Sandu Pharmaceuticals Publishes Second 100-Day Campaign Notice for KYC Updates
Sandu Pharmaceuticals Limited has published a newspaper notice regarding the Second 100-Day Campaign 'Saksham Niveshak' for KYC updates and shareholder engagement, following SEBI guidelines. The campaign runs from April 1 to July 9, 2026, with MUFG Intime India Private Limited serving as the Registrar and Transfer Agent to facilitate the process.

*this image is generated using AI for illustrative purposes only.
Sandu Pharmaceuticals Limited has published a newspaper notice regarding the Second 100-Day Campaign 'Saksham Niveshak' for KYC updates and shareholder engagement, following SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. The company submitted the newspaper publication notice to the Bombay Stock Exchange on April 4, 2026, as part of its regulatory compliance under Regulation 30.
Campaign Details and Timeline
The Second 100-Day Campaign 'Saksham Niveshak' is an initiative by the Investor's Education and Protection Fund Authority (IEPFA) designed to facilitate direct payment of unclaimed dividends to eligible shareholders. The campaign focuses on shareholders whose dividends remain unclaimed, with particular emphasis on KYC updates and related compliance measures.
| Campaign Parameters: | Details |
|---|---|
| Campaign Name: | Saksham Niveshak |
| Duration: | April 1, 2026 to July 9, 2026 |
| Authority: | Investor's Education and Protection Fund Authority (IEPFA) |
| Reference Circular: | SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 |
| Publication Date: | April 4, 2026 |
Registrar and Transfer Agent Information
Sandu Pharmaceuticals has appointed MUFG Intime India Private Limited as its Registrar and Transfer Agent to facilitate the campaign process. Shareholders with incomplete KYC records or unclaimed dividends are advised to contact the RTA promptly to complete necessary formalities.
| RTA Contact Details: | Information |
|---|---|
| Company: | MUFG Intime India Private Limited |
| Address: | C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083 |
| Phone: | 8108116767 |
| Online Portal: | https://swayam.in.mpmfs.mufg.com |
| Service Request: | https://web.in.mpmfs.mufg.com/helpdesk/ServiceRequest.html |
Special Window for Physical Securities
The notice also highlights a special window available from February 5, 2026 to February 4, 2027 for transfer and dematerialization of physical securities. This facility covers transfer requests that were previously submitted but rejected, returned, or remained in process. Securities transferred under this special window will be credited only in demat mode and subject to a one-year lock-in period from the date of registration.
Compliance and Shareholder Action
The company emphasizes that dividends remaining unclaimed for seven consecutive years are liable to be transferred to the IEPFA along with corresponding shares. Shareholders are urged to take prompt action during the campaign period to safeguard their entitlements and ensure compliance with statutory requirements. The detailed circular and additional information are available on the company's website at https://sandu.in/circulars-to-investors/ .
Historical Stock Returns for Elixir Capital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.93% | -0.39% | -12.89% | -27.84% | -33.01% | +196.48% |
What percentage of Sandu Pharmaceuticals' total shareholding consists of unclaimed dividends that could potentially be transferred to IEPFA?
How might the success rate of this second campaign compare to the first 'Saksham Niveshak' initiative in terms of shareholder response and KYC compliance?
Will the one-year lock-in period for dematerialized physical securities impact Sandu Pharmaceuticals' trading liquidity or share price volatility?




























